Spectral Diagnostics Net Profit Margin 2010-2025 | EDTXF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Spectral Diagnostics net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Spectral Diagnostics net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$186.8B
Intuitive Surgical (ISRG)	$172.2B
IDEXX Laboratories (IDXX)	$51.2B
Edwards Lifesciences (EW)	$47.8B
Alcon (ALC)	$40B
IQVIA Holdings (IQV)	$32.6B
DexCom (DXCM)	$32B
Mettler-Toledo (MTD)	$27.1B
STERIS (STE)	$24.6B
Waters (WAT)	$17.7B
SONOVA HOLDING (SONVY)	$17.3B
Hologic (HOLX)	$15.3B
Penumbra (PEN)	$10B
Sysmex ADR (SSMXY)	$8.4B
Globus Medical (GMED)	$8.2B
Masimo (MASI)	$7.9B
Teleflex (TFX)	$5.6B
Glaukos (GKOS)	$5.2B
TransMedics (TMDX)	$4.2B
Integer Holdings (ITGR)	$3.8B
LivaNova (LIVN)	$2.9B
Alphatec Holdings (ATEC)	$2.4B
Veracyte (VCYT)	$2.3B
PROCEPT BioRobotics (PRCT)	$2.2B
Artivion (AORT)	$2B
Nihon Kohden (NHNKY)	$1.9B
Elekta AB (EKTAY)	$1.9B
Integra LifeSciences Holdings (IART)	$1.1B
OPKO Health (OPK)	$1.1B
Paragon 28 (FNA)	$1.1B